Company · PLSE
Pulse Biosciences, Inc
Name as listed on its exchange; filed with the SEC as PULSE BIOSCIENCES, INC.
Nasdaq's symbol directory lists PLSE on Nasdaq as “Pulse Biosciences, Inc - Common Stock”.
In the 12 months to Nov 8, 2026: insiders bought on 4 occasions ($200K); 6 company reports (Form 8-K, since May 26, 2026).
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- Teplitsky Liane Rae, Chief Operating Officer bought $200K
Every trade (4)
- BUYTeplitsky Liane Rae, Chief Operating Officer bought $50K
- BUYTeplitsky Liane Rae, Chief Operating Officer bought $50K
- BUYTeplitsky Liane Rae, Chief Operating Officer bought $50K
- BUYTeplitsky Liane Rae, Chief Operating Officer bought $50K
Company reports · SEC Form 8-K
In its own words
Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.
- Other events Nov 6, 2026
- Results of operations and financial condition Nov 5, 2026
- Other events Oct 14, 2026
- Other events Oct 7, 2026
- Entry into a material definitive agreement; Termination of a material definitive agreement Sep 15, 2026
- Other events Sep 15, 2026
Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.